News
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announce review of their January 2016 Research Collaboration and License Agreement (the "2016 Agreement") with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback